First Access To Vaccines Index Published 06/03/2017 by Intellectual Property Watch 3 Comments An “Access to Vaccines Index” was released today in the Netherlands that claims to “reveal the first landscape of vaccine company actions to improve immunisation coverage.”
UN Human Rights Council To Host Expert Panel On Medicines Access This Week 04/03/2017 by William New, Intellectual Property Watch Leave a Comment The United Nations Human Rights Council in Geneva this week will host a panel discussion among a notable range of experts on access to medicines and the controversial UN Secretary-General’s High-Level Panel report issued last September. The panel is expected to lead to a report sent on to the Human Rights Council for possible action next autumn.
Global Fund Names Interim Executive Director Starting In June 04/03/2017 by William New, Intellectual Property Watch 2 Comments The Board of the Global Fund for AIDS, Tuberculosis and Malaria has named Marijke Wijnroks of the Netherlands as interim executive director starting on 1 June until a new director can be selected. The international health financing facility this week decided to restart its director search from scratch after questions arose with the final two candidates to replace current Executive Director Mark Dybul, who will return to the United States at the end of his four-year term on 31 May.
E-Commerce, Access To Medicines Catching On At WTO TRIPS Council 03/03/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The World Trade Organization committee on intellectual property rights met this week with some discussion items that departed from past agendas but are becoming more familiar. A discussion on electronic commerce revealed interest from members, despite a slow start on details. And discussions on the United Nations High-Level Panel on Access to Medicines prompted nourished interactions and a wish by some countries to pursue the subject in future sessions.
What Is Fair Pricing For Medicines? WHO-Netherlands Forum Aims To Find Out 01/03/2017 by William New, Intellectual Property Watch 4 Comments Public health stakeholders – and just about everyone else – may take notice of a meeting planned for May in the Netherlands, as it could offer the beginning of a new approach to pharmaceutical costs. High drug prices have become a ‘kitchen table’ issue in countries of all economic sizes recently, and the World Health Organization is teaming up with the Dutch government to address it in a new and practical way.
A Look At Latest Figures On R&D For Neglected Diseases 01/03/2017 by Kim Treanor for Intellectual Property Watch 2 Comments Financing for research and development into so-called neglected diseases – those predominantly affecting lower-income populations – rose recently mainly due to the Ebola outbreak, and private sector contributions represent a bigger share, according to the latest available data from a Gates Foundation-supported database.
Rare Diseases: Pharma Industry Calls For Collaboration, Political Commitment For Research 01/03/2017 by Intellectual Property Watch 2 Comments Big Pharma wants to develop treatments for rare diseases, with government support. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week launched a new report describing policy priorities to increase research and development into rare diseases.
Global Fund Hits Reset On Executive Director Search 28/02/2017 by William New, Intellectual Property Watch 4 Comments The Global Fund to Fight AIDS, Tuberculosis and Malaria is deliberating on how to start over on its search for a new executive director after questions arose near the end of the process.
South Centre Paper Sees IP In Free Trade Agreements Interfering With UN SDGs 27/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment A new paper from the intergovernmental South Centre argues that intellectual property provisions in recent free trade agreements would impair countries trying to fulfil the United Nations Sustainable Development Goals. Image Credits: South Centre
WHO Issues First List Of Potential Deadly Bacteria If No New Antibiotics Are Found 27/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Microbial resistance to antibiotics has been rising and the world is now facing the serious possibility of falling back to the days when infectious diseases were hardly treatable. The World Health Organization today published a list of bacteria for which new antibiotics are most urgently needed, to help with the race against time, as the medical world is running out of treatment options.